Ephrin A2 antibody
Quick Overview for Ephrin A2 antibody (ABIN2720262)
Target
See all Ephrin A2 (EFNA2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
- 
    - 
                                            Purification
- Purified from mouse ascites fluids by affinity chromatography
- 
                                            Immunogen
- Full length human recombinant protein of human EFNA2 (NP_001396) produced in HEK293T cell.
- 
                                            Isotype
- IgG2a
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- WB 1:2000, IF 1:100, FLOW 1:100
- 
                                            Comment
- 
                        The concentration of the product may vary between diferrent lots. 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 0.5-1.0 mg/mL
- 
                                            Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - Ephrin A2 (EFNA2)
- 
                                            Alternative Name
- EFNA2
- 
                                            Molecular Weight
- 21.3 kDa
- 
                                            Gene ID
- 1943
- 
                                            NCBI Accession
- NM_001405
- 
                                            HGNC
- 1943
 Target
- 
                    
 
                                     
                                     
                                    